The Role of Type I Interferons in the Pathogenesis and Treatment of COVID-19
Type I interferons (IFN-I) were first discovered over 60 years ago in a classical experiment by Isaacs and Lindenman, who showed that IFN-Is possess antiviral activity. Later, it became one of the first approved protein drugs using heterologous protein expression systems, which allowed its large-sca...
Main Author: | Gideon Schreiber |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.595739/full |
Similar Items
-
A Role of Variance in Interferon Genes to Disease Severity in COVID-19 Patients
by: Leonid Gozman, et al.
Published: (2021-09-01) -
Circulating Type I Interferon Levels and COVID-19 Severity: A Systematic Review and Meta-Analysis
by: Rafaela Pires da Silva, et al.
Published: (2021-05-01) -
Interferon-α2b Treatment for COVID-19
by: Qiong Zhou, et al.
Published: (2020-05-01) -
Dysregulated Interferon Response Underlying Severe COVID-19
by: LeAnn Lopez, et al.
Published: (2020-12-01) -
Type I Interferons in COVID-19 Pathogenesis
by: Enrico Palermo, et al.
Published: (2021-08-01)